Department of Immunology, Center for Immunotherapy, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing, China.
Nat Commun. 2024 Nov 25;15(1):10224. doi: 10.1038/s41467-024-54674-4.
Uncontrolled TLR signaling can cause inflammatory immunopathology and trigger autoimmune diseases. For example, TLR7 promotes pathogenesis of systemic lupus erythematosus. However, whether RNA structural changes affect nucleic acids-sensing TLRs signaling and impact disease progression is unclear. Here by iCLIP-seq we identify a TLR7-binding long non-coding RNA, Lnc-Atg16l1, and find that it promotes TLR7 and other MyD88-dependent TLRs signaling in various types of immune cells. Depletion of Lnc-Atg16l1 attenuates development of TLR7-linked autoimmune phenotypes in the mouse SLE model. Mechanistically, we find that Lnc-Atg16l1 binds to TLR7 at bases near U84 and MyD88 at bases around A129. The analysis of Lnc-Atg16l1 in situ structures show that it strengthens the interaction between TIR domain of TLR7 and MyD88 through specific stem-loop structure changes as a molecular scaffold after TLR7 activation to promote TLR7 downstream signaling. Therefore, we discover a mechanism for host RNA regulation of innate signaling and autoimmune disease through its structural changes. These findings provide insights into the pro-inflammatory function of self RNA in a structure-dependent manner and suggest a potential target for TLR-related autoimmune disorders.
未控制的 TLR 信号可导致炎症性免疫病理学,并引发自身免疫性疾病。例如,TLR7 促进全身性红斑狼疮的发病机制。然而,RNA 结构变化是否影响核酸感应 TLRs 信号并影响疾病进展尚不清楚。在这里,我们通过 iCLIP-seq 鉴定了 TLR7 结合的长非编码 RNA Lnc-Atg16l1,并发现它在各种类型的免疫细胞中促进 TLR7 和其他 MyD88 依赖性 TLRs 信号。Lnc-Atg16l1 的耗竭可减轻小鼠 SLE 模型中 TLR7 相关自身免疫表型的发展。从机制上讲,我们发现 Lnc-Atg16l1 在 TLR7 附近的 U84 碱基和 MyD88 附近的 A129 碱基上与 TLR7 结合。Lnc-Atg16l1 的原位结构分析表明,它通过在 TLR7 激活后作为分子支架特异性改变茎环结构来增强 TLR7 和 MyD88 的 TIR 结构域之间的相互作用,从而促进 TLR7 下游信号。因此,我们发现了宿主 RNA 通过其结构变化调节先天信号和自身免疫性疾病的机制。这些发现以结构依赖的方式提供了自我 RNA 在促炎功能方面的见解,并为 TLR 相关自身免疫性疾病提供了一个潜在的靶点。